Cataracts are the leading cause of treatable blindness world-wide. Surgically removing a symptomatic cataract improves a person’s visual function and overall quality of life. Small-incision phacoemulsification is currently the standard of care for cataract surgery, and is touted as one of the most frequently performed surgeries in developed countries.1 Complications of cataract surgery can lead to edema of the macula, pseudophakic cystoid macular edema (PCME), and potential decrease in vision. Prevention and treatment of PCME is a heavily debated topic in ophthalmology. Literature does not support a best practice method for preventing PCME and therefore, it is questioned what is the safest, most potent prophylactic drug regimen that is cost effective for the cataract patient. This paper discusses PCME, the role of anti -inflammatory agents, the research in prevention of PCME, and how the lack of a best practice method affects the patient.
DeTore, Joanne and DeTore, Suzanne
"Preventing Pseudophakic Cystoid Macular Edema Postoperatively: Are Topical Nonsteroidal Anti-inflammatory Drugs Necessary?,"
Lynchburg Journal of Medical Science: Vol. 1
, Article 20.
Available at: https://digitalshowcase.lynchburg.edu/dmscjournal/vol1/iss3/20
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.